Ian Frazer

Professor Frazer is a world-renowned and internationally educated clinician scientist and clinical immunologist, who uses his expertise and reputation to advise and drive Microba’s mission of powering medical innovation forward. As co-inventor of the technology behind internationally utilised cancer-preventing HPV vaccines Gardasil and Cervarix, Professor Frazer is a leader in translating research into useful clinical outcomes. Bringing more than 40 years’ experience to Microba’s Medical Advisory Board, he is well placed to advise on the company’s therapeutics and diagnostics programs, sit as Deputy Chairman of the Board and to advocate for unmet clinical needs in the IBD space. His expertise is communicated across hundreds of primary and co-authored journal articles and he continues to work on new vaccine technologies as the Head of the Cancer Immunology Group at UQ . He is the former Director of Research at the Translational Research Institute in Brisbane and is currently a Professor at The University of Queensland (UQ), making him a leader in Australian research and clinical translation. Professor Frazer is internationally respected, with qualifications from the University of Melbourne and the University of Edinburgh.